Jupiter, FL, United States of America

Leslie Odame Ofori

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Jupiter, FL (US) (2018 - 2022)
  • San Diego, CA (US) (2023)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Leslie Odame Ofori

Introduction

Leslie Odame Ofori is a notable inventor based in Jupiter, Florida, recognized for his significant contributions to the field of biomedical imaging and therapeutic payloads. With a total of eight patents to his name, Ofori has made strides in developing advanced technologies that enhance medical procedures and patient outcomes.

Latest Patents

Among his latest patents, Ofori has developed "Protease-activated contrast agents for in vivo imaging." This innovation provides compounds that serve as contrast agents in image-guided surgery. These compounds include a latent cationic lysosomotropic fragment that becomes detectable upon cleavage by lysosomal proteases within treated tissues, particularly in tumors and other diseased areas. Additionally, he has introduced "Silanol based therapeutic payloads," which comprise a silanol terminus, a divalent spacer moiety, and a drug moiety capable of targeting specific cells or tissues.

Career Highlights

Ofori has worked with prominent organizations such as BlinkBio, Inc. and Leland Stanford Junior University. His work in these institutions has allowed him to push the boundaries of medical technology and contribute to innovative solutions in healthcare.

Collaborations

Throughout his career, Ofori has collaborated with talented individuals, including Hanh Nho Nguyen and Jutta Wanner, who have contributed to his research and development efforts.

Conclusion

Leslie Odame Ofori's innovative work in the field of biomedical imaging and therapeutic payloads showcases his dedication to improving medical practices. His patents reflect a commitment to advancing technology for better patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…